After being activated by antigens, costimulation and inflammation, naive CD8 + T cells initiate a program of clonal expansion and differentiation that results in widespread changes in the expression of genes encoding molecules involved in the cell cycle, metabolism, effector function, apoptosis and homing [1] [2] [3] [4] . That large-scale transcriptional reprogramming results in irreversible and heritable alterations in the function of the cell and in the fate of its progeny. Several transcription factors (TFs), including T-bet, Eomes, Runx3, Id2 and Blimp-1, are known to regulate the expression of genes encoding molecules essential for CD8 + effector T cells, such as interferon-γ (IFN-γ) and perforin [5] [6] [7] . However, CD8 + T cells that lack T-bet, Eomes, Id2 or Blimp-1 acquire many features of normal effector T cells and are able to form T cell memory [8] [9] [10] [11] [12] [13] . One interpretation of those relatively mild defects in settings of deficiency in a single TF is that functional redundancy exists between TFs known to be involved in the differentiation of CD8 + effector T cells. Alternatively, or in addition, other TFs may exist that are upstream and/or more fundamental in regulating the differentiation of CD8 + T cells.
BATF is a basic leucine zipper TF with an important role in regulating differentiation and function in many lymphocyte lineages [14] [15] [16] [17] [18] . In the CD8 + T cell lineage, increased expression of BATF in exhausted CD8 + T cells suppresses their effector function 19 . In the CD4 + T cell lineage, BATF is required for the differentiation of interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) 14 , in which it binds cooperatively with the TF IRF4 (refs. [20] [21] [22] and its dimerization partners c-Jun, JunB and JunD 18 . BATF also serves an important role in the development of follicular helper T cells (T FH cells) by regulating the TFs Bcl-6 and c-Maf 15, 16 . In addition, BATF is required for class-switch recombination in B cells and for regulating the cytidine deaminase AID 16 , as well as serving as a DNA-damage checkpoint in the self-renewal of hematopoietic stem cells 23 . Chromatin immunoprecipitation and high-throughput sequencing (ChIP-Seq) studies of T H 17 cells have suggested that BATF, in concert with other TFs, may serve a critical role in regulating the expression of many lineagespecific genes, possibly by functioning as a 'pioneer factor' that nucleates transcriptional complexes at key regulatory regions 22 . The role of BATF in the effector differentiation of CD8 + T cells, in contrast, is not fully understood.
We found that BATF was a central regulator of the early differentiation of effector CD8 + T cells. CD8 + T cells that lacked BATF had a profound inability to undergo normal naive-to-effector differentiation and proliferative expansion. ChIP-Seq and transcriptional profiling studies showed that BATF bound to and/or promoted the expression of key transcriptional regulators of effector differentiation (T-bet, Blimp-1 and Runx3), cytokine receptors and their signal transducers (for example, IFNAR, IL-12R, IL-2R and STAT proteins). However, BATF also repressed many genes encoding effector molecules downstream of those TFs and cytokine signaling pathways (IFN-γ and A r t i c l e s granzyme B). The absence of BATF resulted in a nearly complete collapse in the effector differentiation of CD8 + T cells shortly after activation, and that collapse was associated with substantial defects in cellular metabolism, proliferation and survival pathways. The dual role of BATF in upregulating the expression of effector TFs while restraining the expression of effector molecules may provide a regulatory circuit that sets the threshold for commitment to an effector CD8 + T cell fate.
RESULTS
BATF is required for the effector differentiation of CD8 + T cells BATF expression is upregulated in effector CD8 + T cells responding to infection with lymphocytic choriomeningitis virus (LCMV) and remains higher in memory CD8 + T cells than in naive CD8 + T cells 19 . We therefore sought to determine whether BATF has a role in regulating the effector CD8 + T cell response in vivo. We infected mice with homozygous (Batf −/− ) or heterozygous (Batf +/− ) deficiency in BATF and wild-type mice with the Armstrong (Arm) strain of LCMV, which initiates an acute infection, and used tetramers to track the resulting CD8 + T cell response to the LCMV gp33 epitope. We found significantly fewer LCMV gp33-H-2D b -specific CD8 + T cells in Batf −/− mice than in Batf +/− or wild-type mice at the peak of the effector response (day 8 after infection) as well as at later time points (days 15, 22 and 40 after infection) ( Fig. 1a,b) . That finding was not due to altered tissue distribution, as we found a similar lower number of cells in the spleen and other organs ( Fig. 1c and data not shown). The phenotype of naive CD8 + T cells in Batf −/− mice seemed to be similar to that of cells from wild-type mice (data not shown), and thymic development has been reported to be unperturbed in the absence of Batf 14 . These results suggested a defect in the activation and effector differentiation of CD8 + T cells without BATF.
Batf −/− effector CD8 + T cells displayed a CD27 lo CXCR3 lo KLRG1 hi CD127 lo phenotype (Supplementary Fig. 1a ) and sustained higher granzyme B protein expression in the memory phase ( Supplementary   Fig. 1b) , which together was consistent with a more activated and/or terminally differentiated phenotype 3, 7 . However, expression of both T-bet and Eomes protein was lower in Batf −/− CD8 + T cells than in their wild-type counterparts ( Supplementary Fig. 1c ), which suggested that the increase in KLRG1 + effector or memory Batf −/− CD8 + T cells was not simply due to a sustained increase in T-bet and/or Eomes 10 . The defect in the generation of effector T cells after infection with LCMV was not limited to CD8 + T cells. We found that the virus-specific CD4 + T cell response was also considerably diminished in Batf −/− mice ( Supplementary Fig. 1d-g) . Those defects in primary T cell responses resulted in a substantial defect in viral control, as mice that lacked BATF failed to contain the replication of LCMV in vivo (Fig. 1d) . Thus, lack of BATF resulted in substantially defective clonal proliferation of effector CD8 + and CD4 + T cells and altered effector differentiation.
BATF is required in a CD8 + T cell-intrinsic way BATF is involved in multiple cell lineages of the immune system 17 , and it is unclear whether the defects in effector CD8 + T cells described above were due to an intrinsic role of BATF or were secondary effects of failed viral control. To directly assess whether the requirement for BATF in the effector differentiation of CD8 + T cells was cell intrinsic, we adoptively transferred congenically distinct Batf −/− and Batf +/+ P14 CD8 + T cells (which are specific for the LCMV gp33 epitope presented on H-2D b ), at a ratio of 1:1, into naive wild-type recipients ('mixed P14 chimeras'). Then, 1 d later, we infected the host mice with LCMV Arm. The naive Batf −/− and Batf +/+ P14 CD8 + cells were phenotypically similar at transfer ( Supplementary Fig. 2a ). However, by day 8 after infection, the number of Batf −/− P14 effector CD8 + T cells was much lower (up to 400-fold) than that of Batf +/+ P14 cells ( Fig. 2a) . The ratio of Batf −/− P14 cells to Batf +/+ P14 cells was relatively stable after the effector phase (day 8 after infection) through the long-term memory stage (day 200 after infection and beyond) ( Fig. 2b) , which suggested that the critical requirement for BATF was a gp33 tetramer npg in initial effector differentiation and clonal proliferation. To exclude the possibility that rejection of Batf −/− CD8 + T cells caused the cell loss, we transferred Batf −/− and Batf +/+ P14 cells into lymphoreplete hosts in the absence of infection and found equivalent persistence of both types of cells over 40 d (Supplementary Fig. 2b ). The decrease in the clonal proliferation of Batf −/− P14 effector CD8 + T cells was not a result of competition with Batf +/+ P14 cells or skewed tissue distribution because individual adoptive transfer of Batf +/+ P14 cells or Batf −/− P14 cells into separate recipient mice produced similar results, and the lower frequency of Batf −/− P14 cells was consistent in multiple lymphoid and nonlymphoid organs at both the effector phase and the memory phase ( Supplementary Fig. 3a-c) . In addition, the response of Batf +/− P14 cells was nearly identical to that of Batf +/+ P14 cells ( Supplementary Fig. 3a,b) , which suggested that sufficient expression of BATF for an optimal CD8 + T cell response could be achieved in the absence of one allele of Batf.
We observed a similar defect in the effector differentiation of CD8 + T cells for Batf −/− P14 cells after infection with Listeria monocytogenes or immunization with peptide-pulsed dendritic cells ( Supplementary  Fig. 4 ), which indicated that the requirement for BATF in the effector differentiation of CD8 + T cells was not limited to LCMV infection. The difference in the responses of Batf −/− P14 cells after infection with LCMV versus L. monocytogenes or immunization with dendritic cells may have been due to the greater signal strength and/or antigen dose during infection with LCMV, consistent with published observations on the role of IRF4 in regulating the interpretation of T cell antigen receptor (TCR) signal strength 24 . In addition, modulating inflammation did not overcome the loss of BATF ( Supplementary Fig. 4d-f ), which suggested that the phenotype was either independent of inflammatory signaling or upstream of inflammatory signaling. Thus, the defects in the responses of effector CD8 + T cells in the absence of BATF were cell intrinsic and profound.
We next examined the phenotype and function of effector CD8 + T cells generated in the absence of BATF in the mixed P14 chimeras. We found that Batf −/− effector CD8 + T cells included a higher frequency of CD127 hi KLRG1 lo memory precursor cells 10 than did their Batf +/+ counterparts ( Fig. 2c) , which suggested that the KLRG1 hi phenotype achieved by direct infection of Batf −/− mice was due to prolonged viral infection and/or CD8 + T cell-extrinsic effects ( Fig. 1d and Supplementary Fig. 1a ). However, while Batf −/− and Batf +/+ effector P14 cells showed similar granzyme B expression, the few Batf −/− effector P14 cells remaining at day 8 after infection produced less IFN-γ, tumor-necrosis factor and IL-2 upon restimulation than did their Batf +/+ counterparts 3 (Fig. 2d) , which suggested altered functionality of effector CD8 + T cells lacking BATF. To investigate the underlying mechanisms that might account for the altered differentiation of the surviving Batf −/− P14 cells, we analyzed the expression of T-bet, Eomes and IRF4. At day 8 after infection, virus-specific effector CD8 + T cells had less Eomes and more IRF4 in the absence of BATF than in the presence of BATF, while the Batf −/− cells maintained T-bet expression similar to that of their Batf +/+ counterparts ( Fig. 2e) , although because of the low number of Batf −/− effector CD8 T cells, it was unclear whether this phenotype was a function of the selection of the few aberrantly activated surviving cells. The general effects of 
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A r t i c l e s BATF deficiency on gene expression in most cells might be difficult to assess in that small surviving minority. Next we investigated whether BATF was required for a secondary effector CD8 + T cell response. We generated primary Batf −/− and Batf +/+ memory P14 cells in separate hosts. At day 51 after infection, we purified Batf −/− and Batf +/+ memory CD8 + T cells and transferred equal numbers of each genotype together into secondary hosts. We then infected those recipient mice either with L. monocytogenes expressing the LCMV gp33 epitope or with LCMV Arm. On day 7 after rechallenge, the secondary effector response of Batf −/− CD8 + T cells was much lower than that of their Batf +/+ counterparts ( Fig. 2f) . Thus, while some Batf −/− CD8 + T cells were apparently able to enter the memory pool after primary infection, and Batf −/− memory P14 cells retained a Batf +/+ phenotype ( Supplementary  Fig. 3d ), Batf −/− memory CD8 + T cells were also considerably defective in secondary effector differentiation. BATF was therefore required for the primary and secondary effector differentiation of CD8 + T cells.
Restoring BATF 'rescues' effector CD8 + T cell differentiation
We next investigated whether the defects in the effector differentiation of BATF-deficient CD8 + T cells could be reversed by the reintroduction of BATF. We retrovirally transduced Batf −/− and Batf +/+ P14 CD8 + T cells to express BATF and transferred the transduced cells into infection-matched recipient mice ( Supplementary Fig. 5 ). Reintroducing BATF into Batf −/− cells restored the magnitude of the effector CD8 + T cell response and corrected differentiation, such as the skewed ratio of memory precursor cells to short-lived effector cells 10 (Fig. 3) .
In contrast, overexpression of BATF in Batf +/+ CD8 + T cells did not change the number, phenotype or function of CD8 + T cells ( Fig. 3) , which suggested that in wild-type effector CD8 + T cells, BATF expression was not limiting. We found that Batf −/− cells were strongly dependent on retrovirus-expressed BATF, as the Batf −/− cells transduced to express BATF had a substantial advantage in persistence relative to that of the nontransduced Batf −/− cells ( Fig. 3c) . Thus, the defect in the effector differentiation of Batf −/− CD8 + T cells was overcome by the restoration of BATF expression. These results further supported the proposal of an intrinsic role for BATF in the effector response of CD8 + T cells.
BATF, IRF4 and Jun bind target genes together
To determine the mechanisms for the profound effect of the loss of BATF on effector differentiation, we assembled a map of TF-DNA interactions by ChIP-seq with antibodies to BATF, IRF4, c-Jun, JunD and JunB in effector Batf +/+ P14 CD8 + T cells generated in vitro. Those in vitro effector CD8 + T cells showed a global transcriptional profile similar to that of effector cells generated in vivo during infection with LCMV ( Supplementary Fig. 6 ). To define the chromatin state of TF-bound regions, we also used ChIP-seq with antibodies to the following five histone modifications: monomethylation of histone H3 at Lys4 (H3K4me1), which is associated mainly with enhancers; trimethylation of histone H3 at Lys4 (H3K4me3), which is associated with promoters; acetylation of H3 at Lys27 (H3K27ac), which is found in active regulatory regions; trimethylation of histone H3 at Lys36 (H3K36me3), which is found in transcriptionally active regions; and trimethylation of histone H3 at Lys27 (H3K27me3), a modification found in polycomb-repressed regions 25 .
We identified high-confidence binding regions for each TF (Fig. 4a,c  and Supplementary Fig. 7a ). We examined the chromatin state of the TF-bound regions and found a high fraction of all five TFs bound in active cis-regulatory regions, mostly in enhancers rather than promoters, with very little binding in polycomb-repressed chromatin ( Fig. 4b and Supplementary Table 1 ). There was a highly significant overlap of regions bound by BATF and IRF4 (Fig. 4c) , which almost exclusively bound in close proximity ( Fig. 4d) . Fully 80% of regions in which BATF was bound had a region in which IRF4 was bound within 1 kb ( Fig. 4c,d) . However, there was no strong 'predilection' for which Jun family member associated with regions in which BATF was bound, and each was significantly associated with BATF (P < 1 × 10 −6 (c-Jun, JunB and JunD); Supplementary Fig. 7a ). Binding of BATF and IRF4 together resulted in significantly greater binding density for IRF4 than the binding at regions in which only IRF4 was bound, but binding of BATF and IRF4 together had no effect on the binding of BATF to DNA (P < 2.2 × 10 −16 (Mann-Whitney Test); Supplementary Fig. 7b,c) , which suggested that for IRF4, binding together with BATF may have potentiated TF-DNA interaction strength.
We did de novo motif analysis of regions bound by BATF and IRF4 and those bound by either BATF or IRF4 alone. This analysis examines the nucleotide sequence of a set of TF-bound regions to find over-represented nucleotide motifs without relying on previously described TF-binding motif sequences. Regions to which both BATF and IRF4 bound showed considerable enrichment for both types of the previously described ' AP-1-IRF composite element' (AICE) [20] [21] [22] ( Fig. 4e) . In contrast, BATF-only peaks showed enrichment for only the AP-1-binding motif (Fig. 4e) . However, the IRF4-only peaks also showed enrichment for AP-1 and AICE motifs ( Fig. 4e) , which might suggest that IRF4 may cooperatively bind DNA together with other members of the AP-1 TF family in effector CD8 + T cells. We also found that regions bound by BATF in effector CD8 + T cells and in T H 17 cells showed a degree of similarity that was unexpected, given the disparate natures of the two cell types ( Supplementary Table 2 ). Thus, BATF, together with its dimerization partners c-Jun, JunB and JunD, bound extensively in effector CD8 + T cells, largely in combination with IRF4, at motifs with enrichment for AICEs.
BATF and IRF4 dynamically regulate effector-cell genes We identified 'BATF target genes' as those with BATF-bound regions within a window spanning the gene and extending 5 kilobases in both the 5′ direction and 3′ direction. Inspection of those BATF target genes revealed that a large number encoded molecules with functions critical for the effector differentiation of CD8 + T cells ( Table 1) . BATF bound to regulatory regions in genes encoding many TFs with previously known roles in regulating the effector differentiation of CD8 + T cells, including Tbx21 (T-bet) 9,10 , Eomes (Eomes) 8, 9 , Prdm1 (Blimp-1) 11, 12 and Id2 (Id2) 13 . BATF target genes also included those encoding molecules involved in signaling via the TCR (Cd28, Cd3d and Csk), as well as those encoding molecules that control the response to inflammation, such as genes encoding various STAT proteins, and Il12rb1, Il12rb2, Il18rap, Ifngr2, Il6st, Ifnar1, Ifnar2 and Il1r1. BATF also bound to genes encoding molecules required for effector function (for example, Gzmb, Ifng and Il2), homing (for example, Sell, Selp and Ccr9), apoptosis (for example, Bcl2, Bcl2l1 and Mcl1) and metabolism (for example, Gsk3a, Rptor and Rps6ka1), which suggested a major role for BATF in regulating critical genes in effector CD8 + T cells. 
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A r t i c l e s
We analyzed published gene-expression data obtained with naive, effector and memory CD8 + T cells 2 and determined whether BATF target genes were over-represented among genes with a difference in expression during effector differentiation versus memory differentiation. BATF target genes represented 11-17% of all genes with a difference in expression in naive CD8 + T cells versus effector CD8 + T cells or in naive CD8 + T cells versus memory CD8 + T cells (data not shown), a fraction far greater than expected by chance (Fig. 5a) . The greatest enrichment for BATF target genes was among those with a difference in expression in naive CD8 + T cells versus cells in any subsequent time point in effectormemory differentiation (Fig. 5a) . That was consistent with the early upregulation of BATF expression and with the profound requirement for BATF in the naive-to-effector transition ( Fig. 2a,b) . Thus, BATF bound to a set of genes encoding functionally critical molecules that were dynamically regulated during effector and memory differentiation.
Combinations of TFs regulate temporal gene expression
Because BATF bound to regulatory regions in combination with IRF4, JunB, c-Jun and JunD, we assessed whether the kinetics of BATF target-gene expression during effector-memory differentiation varied depending on whether BATF target genes were also bound by IRF4 or members of the Jun family (c-Jun, JunB and JunD). We first mapped genome-wide combinatorial binding patterns of all five TFs studied by merging the binding regions for BATF, IRF4, c-Jun, JunB and JunD that were in close proximity to each other to define seven clusters of regions bound by combinations of TFs (Fig. 5b) . Most BATF-bound regions were also bound by IRF4 and one member of the Jun family (clusters 3-5). However, some regions were associated only with BATF (cluster 1) or only IRF4 (cluster 2). We also identified two clusters (clusters 6 and 7) consisting of regions bound by members of the Jun family independently of BATF; these possibly represented targets of canonical AP-1 complexes.
Next we separately identified three broad temporal patterns of gene expression ( Fig. 5c) during the effector-memory differentiation of CD8 + T cells. The first (pattern A) showed a gradual upregulation during differentiation and showed enrichment for genes classified by Gene Ontology 26 as encoding molecules involved in lymphocyte activation (P = 1.4 × 10 −2 ; hypergeometric test) and migration (P = 1.83 × 10 −2 ). A second pattern (B) included genes transiently upregulated in effector cells and showed enrichment for genes encoding molecules involved in mitosis (P = 7.14 × 10 −9 ) and regulation of the cell cycle (P = 9.9 × 10 −9 ). Finally, a third pattern (C) included genes initially downregulated in effector cells but with gradually recrudescent expression in memory CD8 + T cells and showed enrichment for genes encoding molecules involved in lymphocyte costimulation (P = 3.01 × 10 −4 ) and lymphocyte differentiation (P = 1.33 × 10 −3 ). We then assessed whether the genes bound by the specific combinations of TFs defined above (Fig. 5b) were associated with the particular temporal patterns of gene expression we defined (Fig. 5c) . None of those temporal patterns showed significant enrichment (Fig. 5d) for genes bound by BATF or IRF4 alone (clusters 1 and 2, Fig. 5b) . However, patterns A and C (i.e., groups of genes encoding molecules involved in activation and differentiation of T cells) showed significant enrichment (Fig. 5d) for genes bound by BATF and IRF4 with or Tbx21  Cd28  Il12rb2  Gzmb  Cd44  Bcl2l1  Gpi1  Eomes  Ctla4  Il18rap  Ifng  Cxcr3  Casp3  Hk2  Prdm1  Lag3  Il2ra  Il18  Ccr1  Bcl2  Acly  Rora  Cd86  Il2rb  Ccl3  Ccr2  Mcl1  Cs  Runx1 Tnfrsf8
Il1r2 Rps19
Examples of genes to which BATF binds, organized by functional class of their products. npg without members of the Jun family (clusters 3 and 4). In contrast, pattern B (i.e., the group of genes encoding proliferation-associated molecules that were transiently upregulated in effector cells but returned to baseline expression during the memory phase) was significantly under-represented in genes bound by BATF and IRF4 with or without Jun (Fig. 5d) .
Genes bound by members of the Jun family without BATF or IRF (cluster 7) showed a reciprocal pattern: pattern B showed significant enrichment for those, and patterns A and C showed significant underrepresentation of them (Fig. 5d) , consistent with a role for canonical AP-1 regulation of immediate-early genes and those encoding molecules involved in proliferation 27 . Thus, BATF-bound genes were restricted to a specific temporal sequence by the binding of other TFs to the same region. Genes bound by BATF and IRF4 together, with or without TFs of the Jun family, were persistently upregulated or downregulated after naive T cells differentiated into effector cells (patterns A and C; Fig. 5c,d) . In contrast, groups of genes that were transiently upregulated and then reverted to low expression (pattern B) tended not to include BATF targets but instead showed enrichment for AP-1 targets (data not shown). Thus, the kinetics of gene expression during the effector and memory differentiation of CD8 + T cells was temporally regulated by different combinations of BATF-, IRF4-and Jun-binding events.
Loss of BATF perturbs the expression of a network of TFs
To identify genes whose expression was altered by loss of BATF, we compared the gene-expression profiles of naive Batf −/− and Batf +/+ P14 CD8 + T cells and effector cells of each genotype generated after in vitro activation for 3 d (Fig. 6a) . We found that the profiles of Batf −/− and Batf +/+ effector CD8 + T cells showed considerable differences (Fig. 6a) . In contrast, the expression profiles of naive Batf +/+ or Batf −/− CD8 + T cells were more closely related, consistent with the phenotypic analyses (Supplementary Fig. 2a ). As expected, the pool of BATF target genes showed considerable enrichment for genes perturbed by loss of BATF (P = 9.1 × 10 −22 ). Inspection of the list of genes perturbed by loss of BATF revealed two striking features. First, we found that genes encoding molecules involved in effector function (for example, Prf1 and Ifng) had significantly higher expression in Batf −/− effector cells than in their Batf +/+ counterparts (Fig. 6b) , which suggested that BATF inhibited the expression of those genes. Second, we found that the expression of a large number of TFs was perturbed by loss of BATF (Fig. 6b,c) . To visualize the network of TFs with which BATF interacts, we combined our BATF ChIP-Seq data, expression profiles of Batf −/− CD8 + T cells and published data of TF binding patterns to create an interaction network. This network analysis revealed a dense set of interconnected relationships between BATF and a large set of TFs mediated by direct binding, mutual regulation and shared target genes ( Fig. 6c  and Supplementary Fig. 8 ). The expression of many of those interacting TFs was upregulated or downregulated in BATF-deficient effector cells (Fig. 6c) , which suggested that they were directly regulated by BATF. Other TF-encoding genes bound by BATF did not have a difference in expression in BATF-deficient effector cells ( Supplementary  Fig. 8 , gray in outer circle), which suggested that BATF regulated their expression at a different time point or that their expression was regulated by BATF in combination with other TFs. Many of the TFs that were perturbed by loss of BATF have known, critical roles in the effector differentiation of CD8 + T cells. We identified a lack of induction or downregulation of the expression of Id3, T-bet (Tbx21), Blimp-1 (Prdm1) and Runx3 in Batf −/− effector cells at early time points after activation (Fig. 6b,c and Supplementary Fig. 8) , which suggested that BATF reinforced the effector differentiation of CD8 + T cells by inducing the expression of those TFs. Loss of BATF increased Eomes expression ( Fig. 6c and Supplementary Fig. 8) , potentially indicative of a role for BATF in ensuring the reciprocal expression of T-bet and Eomes observed in CD8 + T cells 28 . We found that Batf −/− effector CD8 + T cells had higher expression of IRF4 and c-Jun than did their Batf +/+ counterparts ( Fig. 6c and Supplementary Fig. 8) , which suggested that BATF may provide negative feedback on the expression of those binding partners.
BATF is required early during effector differentiation
The binding of BATF to a broad set of genes encoding molecules critical to the effector differentiation of CD8 + T cells suggested that BATF may serve an essential role at the earliest stages of effector differentiation by specifying the key properties of effector CD8 + T cells. To assess npg A r t i c l e s this, we tracked the effector differentiation of Batf −/− and Batf +/+ P14 CD8 + T cells during the first 96 h after infection with LCMV. Batf +/+ CD8 + T cells started to proliferate by day 2 after infection and then entered an exponential proliferation state (Fig. 7a,b) . In contrast, although Batf −/− P14 cells also initiated proliferation with similar kinetics (Fig. 7a) , they showed a substantial collapse in numbers at day 4 after infection (Fig. 7a,b) , which suggested a key role for BATF in coordinating the earliest events in the naive-to-effector transition of CD8 + T cells. Batf −/− CD8 + T effector cells exhibited higher caspase activity (as assessed with the fluorescence-labeled caspase inhibitor FLICA) and expression of CD95 (Fas) and lower expression of Bcl-2 ( Fig. 7c and Supplementary Fig. 9a ), which suggested that enhanced cell death was a cause for the collapse during proliferative expansion. A small number of cells seemed to survive that collapse in clonal expansion at day 4 after infection, and those cells may have given rise to the small number of effector CD8 + T cells observed at day 8 after infection ( Figs. 1 and 2) .
To determine whether BATF could bind at that early stage of the effector differentiation of CD8 + T cells, we analyzed the time course of BATF-DNA interactions at four regions in representative target genes by ChIP-PCR. BATF bound to all four genes examined starting at day 1 (Supplementary Fig. 9b ). This indicated that BATF could bind to its target genes at the earliest stage (i.e., within 24 h) of differentiation.
One key feature of the naive-to-effector transition for CD8 + T cells is a switch from a mainly catabolic metabolism for naive T cells to the anabolic or glycolytic metabolic program needed to support exponential proliferation and synthesis of biomass that accompanies blastogenesis and rapid division as well as production of effector molecules. We hypothesized that activated CD8 + T cell would fail to make those metabolic changes in the absence of BATF. Indeed, at day 3 after infection, before the proliferative collapse, Batf −/− P14 cells were smaller than their Batf +/+ counterparts, as assessed by forward scatter (Fig. 7a) . Moreover, Batf −/− CD8 + T cells had lower expression of key nutrient transporters or receptors (CD71 and CD98) and less production of reactive oxygen species (as determined by staining with a fluorogenic probe for measuring cellular oxidative stress) than did their Batf +/+ counterparts, consistent with mitochondrial changes and less phosphorylation of the ribosomal protein S6 downstream of the metabolic checkpoint kinase mTOR (Fig. 7d) , which indicated a role for BATF in the metabolic reprogramming that accompanies the effector differentiation of CD8 + T cells.
Despite those profound defects, Batf −/− P14 cells initially upregulated their expression of the cytokine receptor CD25 (IL-2Rα) and the activation marker CD69 to a degree similar to that of Batf +/+ P14 cells (Supplementary Fig. 9c ), which suggested that TCR-dependent early activation events were preserved in the absence of BATF. However, Batf −/− P14 cells showed impaired upregulation of the expression of T-bet ( Fig. 7e) and did not upregulate expression of the cytokine receptors CD212 (IL-12Rβ1) and CD218a (IL-18Rα). The defect in the expression of CD212 (IL-12Rβ1) and CD218a (IL-18Rα) protein at day 2 after infection preceded the defect in T-bet protein expression at day 3 after infection (Fig. 7e,f) . Thus, BATF probably controlled T-bet expression at those early time points both through a direct regulatory effect on the gene and, potentially, through an indirect effect via inflammatory cytokines such as IL-12 that are known inducers of T-bet 7, 10 . At later time points, T-bet expression in the few surviving Batf −/− cells present at day 8 after infection (Fig. 1 ) may have been driven by an altered inflammatory environment. In addition, Batf −/− cells also failed to upregulate the expression of costimulatory molecules such as CD30 and CD134 (OX-40) (Supplementary Fig. 9d ).
These results indicated essential role for BATF in integrating signals 1, 2 and 3 of T cell activation. Despite the lack of efficient upregulation of the expression of upstream effector TFs and cytokine receptors in BATF-deficient cells, genes encoding downstream effector molecules were paradoxically upregulated in the absence of BATF. At day 3 after infection with LCMV, Batf −/− cells displayed inappropriately high expression of CD69 and the activation marker CD62L ( Fig. 7g and Supplementary  Fig. 9c ). That result was not due to altered proliferation kinetics of Batf −/− P14 effector cells, as the expression of CD69 and CD62L in successive generations of proliferating effector cells was different in Batf −/− early effector cells and their Batf +/+ counterparts (Supplementary Fig. 9e ). In addition, Batf −/− cells produced more IFN-γ and granzyme B (Fig. 7h) , both direct targets of BATF ( Figs. 4f and 6b) , with similar trends for other effector cytokines, such as tumor-necrosis factor and CCL3 (MIP-1α) (Supplementary Fig. 9f ). These observations indicated that while BATF was needed to induce key positive regulators of the effector differentiation of CD8 + T cells, including TFs and cytokine receptors, BATF also directly repressed the expression of genes encoding downstream effector molecules. These results suggested that BATF is a critical component of a feed-forward transcriptional circuit that coordinates the gene-expression program of the effector differentiation of CD8 + T cells (Supplementary Fig. 10) . A key feature of this model is the dual induction of the expression of upstream regulators of that differentiation (for example, TFs and genes encoding cytokine receptors) and repression of the expression of target genes encoding downstream effector molecules (for example, IFN-γ and granzyme B), which ensures that the effector differentiation of CD8 + T cells is not 'locked in' until a sufficient threshold of upstream signals is achieved to overcome that latter BATF repression.
DISCUSSION
Several studies have found that BATF regulates the differentiation of T H 17 cells and T FH cells 14, 16, 17 , but its role in CD8 + T cells has remained poorly understood. BATF represses the effector function of exhausted CD8 + T cells 19 and regulates metabolism and/or epigenetics in CD8 + T cells via the histone deacetylase Sirt1 (ref. 29 ). Here we found that BATF orchestrated the developmental transition from a naive state to an effector state in CD8 + T cells. Our data have identified BATF as a checkpoint in a transcriptional circuit that ensures the proper coordination of the effector differentiation of CD8 + T cells. In this circuit, BATF served two distinct and critical functions. First, it directly upregulated the expression of critical TFs associated with the acquisition of effector functions, including T-bet, Runx3 and Blimp-1, as well as that of cytokine receptors and STAT TFs that sense inflammation and reinforce effector differentiation. Second, BATF bound to and/or repressed the expression of downstream effector molecules, such as IFN-γ, perforin and granzyme B. Without BATF, the coordinated sequence of molecular events that occur during the differentiation of effector CD8 + T cells was disrupted, and effector CD8 + T cells reach a differentiation crisis marked by metabolic and proliferative catastrophe within 3-5 d of antigen encounter.
Several TFs regulate the effector differentiation of CD8 + T cells 7 . Naive CD8 + T cells that lack T-bet 9,10 , Blimp-1 (ref. 11), Id2 (ref. 13) or Runx3 (ref. 30) show defects in the magnitude of the effector response, as well as less cytotoxic potential or IFN-γ expression. However, the mechanism that coordinates the upregulation of expression of that set of TFs has been unclear. We found that BATF directly or indirectly regulated a dense network of TFs, including many TFs known to be required for the effector differentiation of CD8 + T cells. In the absence of BATF, the early upregulation of its target genes encoding T-bet, Runx3 and Blimp-1 was impaired, which indicated that BATF may function upstream of each of those TFs to regulate their appropriate temporal induction during the effector differentiation of CD8 + T cells. In addition to directly upregulating the expression of those effector TFs, BATF also bound to and/or upregulated Ifnar1, Ifnar2, Il12rb1 and Il12rb2, which encode receptors for inflammatory cytokines that are critical for the full differentiation of effector CD8 + T cells 10 . Thus, BATF integrates signal 1 (TCR-mediated activation) and signal 3 (sensing of inflammatory cytokines) of T cell activation to ensure commitment to an effector fate.
It may seem counterintuitive that BATF both positively regulated effector TFs while negatively regulating downstream effector molecules, such IFN-γ, perforin and granzyme B. However, in bacteria, yeast and cell lines, circuits that involve opposing actions on downstream genes (called 'incoherent feed-forward loops') are common [31] [32] [33] . BATF positively regulated lineage-specific TFs as well as genes encoding receptors for inflammatory cytokines that are known to reinforce the expression of Tbx21 and other genes encoding effector molecules 10 . The negative arm repressed effector molecules (IFN-γ, perforin and granzyme B) and thus formed an incoherent feed-forward loop. Such loops can serve as 'persistence detectors' that suppress an inappropriate response to a transient or subthreshold burst of stimulation and delay downstream gene expression until a full-fledged stimulus occurs 33 . The simultaneous repression of effector moleculeencoding genes by BATF would ensure that the full effector program is 'locked in' only when the positive regulatory arms have reached a critical threshold to overcome the downstream inhibition mediated by BATF at genes encoding effector molecules. The essentiality of that coordinated deployment of effector functions was demonstrated by the early and profound collapse of the differentiation of effector CD8 + T cells in the absence of BATF.
BATF expression is increased in exhausted T cells during chronic viral infection in humans and mice 19 . In that setting, the main function of BATF seems to be to repress genes encoding effector molecules such as IFN-γ. The dual role we have described for BATF in early T cell activation, however, would suggest that it may be possible to distinguish the distinct effects of BATF on inducing a differentiation program (as BATF does in effector differentiation) from its effects on modulating gene expression once that program is established (as it does in exhausted CD8 + T cells). Such an interpretation would suggest that once CD8 + T cells progress past the point of initial effector differentiation, BATF 'tunes' functionality depending on the strength and/or duration of TCR stimulation. Future studies of the temporal removal of BATF at different stages of infection should reveal further insights into the potential context-specific functions of BATF.
Two published studies have demonstrated that IRF4 is regulated in a TCR signal-strength dependent way and is required for the effector differentiation of CD8 + T cells 24, 34 . Consistent with those findings, we found that BATF and IRF4 acted together to regulate the effector differentiation of CD8 + T cells. The regions bound by BATF and IRF4 overlapped extensively, and the two TFs bound in close proximity at regions showing enrichment for the composite AICE motif, largely consistent with published data from studies of T H 17 cells [20] [21] [22] 35 . We found that the binding of BATF and IRF4 together was functionally cooperative: only genes bound by both TFs (but not npg those bound only by one) were dynamically regulated during effector differentiation, which suggested that the association of both TFs was needed to execute the differentiation program. Although BATF expression is also upregulated in response to TCR signaling 19 , we found that availability of BATF was not limiting in wild-type CD8 + T cells because overexpression of BATF did not further enhance effector differentiation. Moreover, studies of cells lacking only a single allele of Batf demonstrated that sufficient BATF protein was available for the effector differentiation of CD8 + T cells even in the heterozygous setting. Thus, the role of IRF4 may be to contribute a signal strength-sensing component to the activity of the BATF-IRF4 complex 24 . Such TCR signal-induced upregulation of IRF4 expression would be balanced by the negative regulation of IRF4 by BATF, providing a feedback mechanism that would limit the effect of this TF complex and prevent overstimulation during the activation of effector CD8 + T cells.
Why did BATF-deficient effector cells die? BATF-deficient effector cells were able to enter cell cycle but did not increase in number. That phenotype is reminiscent of that of CD8 + T cells that are unable to sense inflammatory cytokines such as type I interferons 36 . However, we found that modulation of inflammation did not alter the response of BATF-deficient CD8 + T cells, perhaps because these cells did not have the appropriately abundant expression of cytokine receptors. During effector differentiation, CD8 + T cells must undergo metabolic reprogramming and shift to an anabolic program that accompanies massive proliferation and increase in biomass 4 . Batf −/− CD8 + T cells did not manifest several important components of that metabolic shift, including increase in cell size, upregulation of the expression of nutrient transporters, optimal activation of mTOR and mitochondrial function. Such changes could have been due to disruption of downstream genes encoding molecules involved in regulating metabolism, as has been reported for IRF4 (ref. 24 ) and BATF 29 . Alternatively, or in addition, dysregulation of a large network of genes encoding TFs, cytokine receptors and effector molecules in the absence of BATF may be perceived as a developmental catastrophe and trigger an apoptotic response preceded by disordered metabolism. Future work should address whether enforced expression of specific, individual BATF targets could 'rescue' the defect in effector differentiation. However, given the broad range of critical genes regulated by BATF, it may be that no single gene product is able to restore normal effector differentiation in the absence of BATF.
Several questions about the role of BATF in regulating effector differentiation remain. BATF is required for the differentiation of T H 17 and T FH cells 14, 16 . Our data examining effector CD8 + T cells showed that BATF orchestrated the transition from naive CD8 + T cell to effector CD8 + T cell and suggested a broad role for BATF across many lymphocyte lineages. It remains unclear, however, how BATF can be required for diverse differentiation programs in different cells. BATF functions as a 'pioneer factor' in T H 17 cells, increasing chromatin accessibility to allow subsequent binding by other TFs 22 . BATF may therefore lay a 'foundation' of open regulatory regions on top of which additional layers of regulation are added through the combined action of stimulus-specific TFs such as STAT proteins 37 and effector TFs such as T-bet and Blimp-1. Future studies should define the 'parts list' of TFs that contribute to each lineage and determine how their layered, combinatorial binding with BATF-IRF4 shapes the identity of developing effector cells.
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